News From Transplant Week of December 2, 2001 / Vol. 2 No. 48

 

Robert Tools Dies; 2nd AbioCor Recipient to Die This Week

 

Robert Tools, who won the hearts of millions of Americans after becoming the recipient of the world's first totally implantable artificial heart, died Friday at Jewish Hospital in Louisville from uncontrolled abdominal bleeding and multiple organ failure.

Tools' death, and the death of a man receiving the 6th artificial heart during surgery earlier in the week in Houston, put a damper on the almost unbridled optimism that has surrounded the clinical trials of the AbioCor mechanical heart for the past five months.

Patients accepted into the AbioCor trial must suffer from otherwise untreatable bi-ventricular heart failure, be too ill to be eligible for human heart transplantation, and have a high probability of dying within 30 days.

When Tools received the implant July 2, doctors said they would be happy if he lived with the new heart for 60 days.

But Tools' recovery exceeded all expectations. Several months after the implant, he was making frequent trips outside the hospital, including lunches at area restaurants, fishing with his physicians and an evening at a comedy club.

Tools' hopes of being discharged from the hospital were dashed, however, when he suffered a serious stroke Nov. 11. Doctors said the bleeding and subsequent organ failure that led to his death were not related to the stroke, nor to complications or a malfunction of the AbioCor device.

"We will miss Bob's laugh, his sense of humor and his fighting spirit,'' said Dr. Rob D. Dowling, one of his surgeons. "Mr. Tools and his family members are heroes. Their willingness to be the first to participate in the AbioCor clinical trial could potentially pave the way for a revolutionary treatment option for advanced heart disease."

Only two days earlier, an unidentified man suffering from chronic heart failure became the first patient of the AbioCor trials to die during efforts to implant a mechanical heart at St. Luke's Episcopal Hospital in Houston. The surgical team spent 20 hours trying to control bleeding during surgery in the man.

Four other patients who have undergone AbioCor implants -- one in Louisville, one in Houston, one in Los Angeles and one in Philadelphia -- are still alive.

"All four right now are in varying stages of recovery," said Ed Berger, Abiomed vice president for strategic policy and planning. "Nobody has gone home, and we don't have the dramatic positive story that eventually we are going to see, but it's very encouraging to us so far."

Abiomed has been granted permission to perform as many as 15 implants, and the company plans to continue with the trial despite Tools's death.

William Schroeder of Jasper, Ind., holds the survival record among artificial-heart recipients, living 620 days with a Jarvik-7 before dying in 1986.

Other sources: Abiomed, Jewish Hospital